We evaluated breast cancer mortality through 1997 among 69 525 female radiologic technologists who were certified in the United States from 1926 through 1982 and who responded to our questionnaire. Risk of breast cancer mortality was examined according to work history and practices and was adjusted for known risk factors. 
High-dose ionizing radiation has been associated with increased breast cancer risk among Japanese atomic bomb survivors (1) (2) (3) and among patients who have received radiotherapy (4), fluoroscopy, or repeated diagnostic x-rays (5) (6) (7) . However, limited data exist regarding breast cancer risks among healthy women who have had chronic radiation exposures at low to moderate doses. For example, although cancer risks have been extensively evaluated for men who work in the nuclear industry (8, 9) , accurate estimates of breast cancer risk among women who work in the nuclear industry are difficult to calculate because relatively few women are so employed and those that are have very low radiation exposures (10) . However, medical radiation workers, who constitute 44% of all radiation workers in the United States and include a high proportion of women, provide a unique opportunity to study breast cancer risks in a healthy population that has chronic exposure to radiation (11) (12) (13) . In the present investigation, we studied 69 525 questionnaire respondents of the 106 884 women in a cohort of 146 022 U.S. radiologic technologists who were certified from 1926 through 1982. Compared with earlier reports on the U.S. radiologic technologist cohort (14, 15) , the present analysis added 7 years of follow-up, used more precise exposure surrogates, and evaluated potential confounding factors not previously examined in analyses of mortality.
Technologists were eligible for this study if they were certified by the American Registry of Radiologic Technologists (ARRT) for at least 2 years from 1926 through 1982 (15, 16) . Of the 106 884 female technologists who met the eligibility requirements, approximately 17 000 who were inactive registrants as of 1982 were traced using state and national databases (16) . Current addresses were available for active registrants through annual recertifications with the ARRT. Deaths were identified through linkage with Social Security mortality files or the National Death Index; causes of death were obtained from death certificates or from the National Death Index Plus and were coded according to the International Classification of Diseases (17) . A selfadministered questionnaire was sent to the 99 234 female technologists who were known to be living and for whom a current address was available to ascertain their lifetime work histories, reproductive and family cancer histories, and other lifestyle factors (16) . There were 69 525 respondents to the questionnaire. General characteristics and mortality rates were similar among respondents and nonrespondents (16) . This study was approved by the Institutional Review Boards of the National Cancer Institute and the University of Minnesota.
Person-years of follow-up were compiled from the date of questionnaire completion to the date of death, last known vital status, or January 1, 1998, whichever occurred first. A total of 860 022 person-years were accumulated. Poisson regression (18) was used to estimate the relative risk (RR) of breast cancer mortality in relation to work history while adjusting for other covariates in the regression model. Analyses were stratified by attained age (a timedependent variable representing age at each calendar year during the followup period) in 5-year age groups, calendar year of follow-up in 5-year categories, and race. Risks were calculated for the total number of years each subject worked as a radiologic technologist and the number of years each subject worked in the following calendar periods-before 1950, 1950 through 1959, 1960 through 1969, and 1970 and later-to reflect potential secular changes in recommended exposure limits (19, 20) . All statistical tests were twosided, and P values for tests of trend were calculated based on the estimated slope of the corresponding continuous variable (18) .
Among the women included in this study, 75% were born between 1940 and *All RRs were stratified for race, attained age, and calendar year of follow-up and were adjusted for age at menopause, age at first birth, and family history of breast cancer. The analysis for all years worked was adjusted for the duration of employment, and the analysis for all time periods was adjusted for the year of first employment.
†The questionnaires of 46 respondents contained insufficient information for analysis and were excluded. Subjects who reported that they were 65 years of age or older at menopause (one breast cancer death and seven women without breast cancer) or who reported first working when they were younger than 10 years old (20 women without breast cancer) were excluded from all analyses. Women with missing values for the year first worked and/or the number of years worked (23 women without breast cancer) and women who never worked as a radiologic technologist (5 breast cancer deaths and 1052 women without breast cancer) were included in this analysis and were coded as separate categories (estimates for these women are not shown in the table).
‡P for trend was based on the slope of the corresponding continuous variable; parentheses indicate negative slope estimates. §Referent group for the joint analysis of the number of years worked and year first worked. Referent group for the separate analysis of number of years worked and year first worked. ¶P values were based on the Wald test statistic. #Analyses were restricted to technologists who were 15-65 years old and therefore eligible for employment in the respective calendar time periods. Analyses were adjusted for employment in other time periods. Table 1) . Risk of death from breast cancer increased statistically significantly (P for trend ‫ס‬ .002) with decreasing calendar year period that technologists first worked ( Table 1 ). The duration of employment as a radiologic technologist was not associated with breast cancer mortality in all time periods combined. Nevertheless, breast cancer mortality increased with an increasing number of years worked prior to 1950 (P for trend ‫ס‬ .018) ( Table 1 ). The lower breast cancer mortality risk associated with working in more recent calendar periods may have been due to the effects of adjuvant therapy. However, we could not control for adjuvant therapy effects, because we did not collect data on the use of this form of treatment for breast cancer.
Risks were also higher among women who first worked with fluoroscopy (P ‫ס‬ .088) or multifilm procedures (P ‫ס‬ .035) before 1950 than among women who first worked with those procedures in 1960 or later. Risk was not associated with first performing routine x-rays (P ‫ס‬ .299) or with the use of radium or other isotopes (P ‫ס‬ .507) before 1950 (Table 2) . Risks were not associated with the number of years that technologists worked with these procedures, either overall or within specific calendar periods. Risk of breast cancer mortality was not associated with the use of lead aprons or the frequency with which technologists held patients who received x-rays. Risks of breast cancer mortality were similar for preand postmenopausal women in relation to work practice-related variables. *All relative risks were stratified for race, attained age, and calendar year of follow-up (latter two are time-dependent) and were adjusted for age at menopause, age at first birth, and family history of breast cancer. The analysis for all years worked was adjusted for the duration of employment using the specific procedure, and the analysis for all time periods was adjusted for the year first worked with the specific procedure.
†We excluded 861 women from this analysis because their questionnaires contained inconsistent values for year of first work and duration of work for specific procedures.
‡P for trend was based on the slope of the corresponding continuous variable; parentheses indicate negative slope estimates. §Referent group for the joint analysis of the number of years worked and year first worked. Referent group for the separate analysis of number of years worked and year first worked. ¶P values were based on the Wald test statistic. նNumber of deaths is different for the different procedure types because technologists with unknown values and technologists who never worked with the specific procedures are not shown. **Multifilm procedures included gastrointestinal series, spinal x-rays, kidney-ureter-bladder films, and intravenous pyelograms.
Breast cancer risks among female Japanese atomic bomb survivors (1) (2) (3) and among women undergoing repeated diagnostic x-rays (6,7) have shown remarkable age-dependence, with risks being highest among women who were younger than 20 years of age at the time of exposure. Most (57%) of the women in our study began working as radiologic technologists when they were between the ages of 18 and 24 years; only 9% began working as radiologic technologists at 25 years old or older (data not shown). Compared with women who began working at age 25 years or older (29 breast cancer cases), the risks of breast cancer mortality for women who began working when they were younger than 18 years, 18-19 years old, and 20-24 years old were 1.46 (95% CI ‫ס‬ 0.82 to 2.59; 82 breast cancer cases), 1.39 (95% CI ‫ס‬ 0.80 to 2.43; 79 breast cancer cases), and 1.58 (95% CI ‫ס‬ 0.93 to 2.66; 65 breast cancer cases), respectively. The limited numbers of technologists who began working before the age of 17 years or after the age of 30 years precluded assessments of the breast cancer risks associated with occupational radiation exposures in these age groups.
This cohort of radiologic technologists is one of the few radiation worker cohorts that contain a substantial number of women (21-23) for whom individual information on lifetime work history and cancer risk factors is available. A previous study among 5400 female Chinese medical x-ray workers who were exposed to occupational radiation between 1950 and 1985 found a 50% increase in breast cancer risk compared with hospital workers who were not exposed to radiation; those exposed before 1960 had a 70% increased risk (21) . Estimated occupational radiation exposures are likely to have been higher among the Chinese medical radiation workers than among American medical radiation workers during the same time periods (13) . Risk for breast cancer incidence was elevated, though it was not statistically significantly higher, among 3404 female Danish medical radiation workers employed from 1954 to 1982 compared with risk among Danish women in the general population (22) . However, risk was not higher among 101 164 women (35% of whom were medical workers) in the Canadian national radiation worker registry who were monitored from 1951 through 1983 than it was among Canadian women in the general population (23) .
Our study included a long follow-up period, a wide range of work practices, and sufficiently large numbers of technologists, which enabled us to make internal comparisons and thus minimize potential biases due to the healthy worker effect. It is difficult, however, to disentangle the effects of other variables (e.g., year of birth, attained age, and the calendar year of follow-up) that might also affect risk estimates. We performed a similar analysis using breast cancer mortality rates from the U.S. general population to estimate the background risks and found that, although the patterns of risk were similar to those we report here, the risk estimates themselves were somewhat smaller. Our finding-that breast cancer mortality was highest among technologists who first worked in the earliest calendar periods-probably reflects changing exposures to radiation over time. Recommended exposure limits for medical radiation workers decreased from 70 rem/year before 1934 to 30 rem/year in 1934, 15 rem/year in 1949, and 5 rem/ year in 1958 (24) . This cohort, with its large number of women, estimated wide range of radiation doses received, and the extensive information available on risk factors, is uniquely suited to address the risks of breast and other cancers that are associated with long-term, low-dose radiation exposure.
